Health Care • Biotechnology: In Vitro & In Vivo Diagnostic Substances
$7.19 ▲ +0.34
(+4.96%)
MKT CAP: $739.9M • VOL: 1.38M
52W L $3 52W H $9
ROARABLE / RQD
D • 44/100
PIOTROSKI
2 / 9
DISCLOSED BUY FLOW
$0
DISCLOSED SELL FLOW
$0
13F HEDGE FUND FILINGS
0 DISCLOSURES
CONGRESSIONAL STOCK ACT
0 FILINGS
ACHV // SEC FORM 4 INSIDERS, 13F WHALES & POLITICIAN LEDGER (OWN <GO>)
WHALE DIRECTORY <13F>
| FILING DATE | FILER / INSTITUTION | CATEGORY | ACTION | SHARES | EXEC PRICE | TOTAL VALUE | DOSSIER |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Citadel Advisors LLC (13F-HR) Institutional Investment Manager | HEDGE_FUND | BUY | 425.0K | $6.90 | $2.9M | TRACK <GO> |
| 2025-02-04 | Executive Officer Form 4 Trust EVP & Chief Financial Officer | INSIDER | SELL | 18.5K | $7.26 | $134.3K | TRACK <GO> |
| 2025-01-28 | Renaissance Technologies LLC 13F Quantitative Holdings | HEDGE_FUND | BUY | 190.0K | $6.76 | $1.3M | TRACK <GO> |